Pediatric nonlymphoblastic non-Hodgkin lymphoma: Baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation - A prospective study

Radiology

Volumn 262, Issue 3, 2012, Pages 956-968

  Bakhshi, Sameer ^a   Radhakrishnan, Venkatraman ^a   Sharma, Punit ^a   Kumar, Rakesh ^a   Thulkar, Sanjay ^a   Vishnubhatla, Sreenivas ^a   Dhawan, Deepa ^a   Malhotra, Arun ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; NONLYMPHOBLASTIC NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TISSUE METABOLISM; TUMOR BIOPSY;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; DIATRIZOATE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IOPAMIDOL; KAPLAN-MEIER ESTIMATE; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84863403424     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110936     Document Type: Article

References (21)

1. Dunleavy K, Mikhaeel G, Sehn LH, Hicks RJ, Wilson WH. The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma. Leuk Lymphoma 2010;51(Suppl 1):28-33.
2. Hutchings M, Loft A, Hansen M, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006;107(1):52-59. (Pubitemid 43053523)
3. Mikhaeel NG. Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now? Leuk Lymphoma 2009;50(12):1931-1936.
4. Bar-Sever Z, Keidar Z, Ben-Barak A, et al. The incremental value of 18F-FDG PET/CT in paediatric malignancies. Eur J Nucl Med Mol Imaging 2007;34(5):630-637. (Pubitemid 46669353)
5. Amthauer H, Furth C, Denecke T, et al. FDG-PET in 10 children with non-Hodgkin's lymphoma: initial experience in staging and follow-up. Klin Padiatr 2005;217(6):327-333. (Pubitemid 41746114)
6. Mody RJ, Bui C, Hutchinson RJ, Frey KA, Shulkin BL. Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma. Leuk Lymphoma 2007;48(4):699-707. (Pubitemid 46605541)
7. Edeline V, Bonardel G, Brisse H, et al. Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: a single center experience. Leuk Lymphoma 2007;48(4):823-826. (Pubitemid 46605560)
8. Depas G, De Barsy C, Jerusalem G, et al. 18F-FDG PET in children with lymphomas. Eur J Nucl Med Mol Imaging 2005;32(1):31-38.
9. Hernandez-Pampaloni M, Takalkar A, Yu JQ, Zhuang H, Alavi A. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatr Radiol 2006;36(6):524-531.
10. Hermann S, Wormanns D, Pixberg M, et al. Staging in childhood lymphoma: differences between FDG-PET and CT. Nucl Med (Stuttg) 2005;44(1):1-7. (Pubitemid 40314093)
11. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 1980;7(3):332-339. (Pubitemid 11228642)
12. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood Bcell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt- Münster Group Trial NHL-BFM 90. Blood 1999;94(10):3294-3306. (Pubitemid 29536122)
13. Link MP, Shuster JJ, Donaldson SS, Berard CW, Murphy SB. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med 1997;337(18):1259-1266. (Pubitemid 27461280)
14. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25(5):579-586. (Pubitemid 350002966)
15. Yang DH, Min JJ, Jeong YY, et al. The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma. Ann Hematol 2009;88(5):425-432.
16. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17(4):1244-1253. (Pubitemid 29162950)
17. Shankar A, Fiumara F, Pinkerton R. Role of FDG PET in the management of childhood lymphomas: case proven or is the jury still out? Eur J Cancer 2008;44(5):663-673.
18. Riad R, Omar W, Kotb M, et al. Role of PET/CT in malignant pediatric lymphoma. Eur J Nucl Med Mol Imaging 2010;37(2):319-329.
19. Miller E, Metser U, Avrahami G, et al. Role of 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients. J Comput Assist Tomogr 2006;30(4):689-694. (Pubitemid 44091528)
20. Terasawa T, Nihashi T, Hotta T, Nagai H. 18F-FDG PET for posttherapy assessment of Hodgkin's disease and aggressive Non-Hodgkin's lymphoma: a systematic review. J Nucl Med 2008;49(1):13-21.
21. Furth C, Steffen IG, Amthauer H, et al. Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. J Clin Oncol 2009;27(26):4385-4391.